BR9903779A - Derivados de aril-ciclohexilamina - Google Patents
Derivados de aril-ciclohexilaminaInfo
- Publication number
- BR9903779A BR9903779A BR9903779-3A BR9903779A BR9903779A BR 9903779 A BR9903779 A BR 9903779A BR 9903779 A BR9903779 A BR 9903779A BR 9903779 A BR9903779 A BR 9903779A
- Authority
- BR
- Brazil
- Prior art keywords
- lower alkyl
- aryl
- tetrahydronaphthyl
- naphthyl
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Abstract
Patente de Invenção: <B>"DERIVADOS DE ARIL-CICLOHEXILAMINA"<D>. A presente invenção se refere à aplicação de compostos da fórmula geral em que Ar¹ é fenila, naftila ou tetraidronaftila, opcionalmente substituída por hidróxi, alcóxi inferior, nitro, amino ou metanossulfonamida; Ar² é fenila, naftila ou tetraidronaftila, opcionalmente substituído por alquila inferior ou halogênio; X é C, CH, C(OH) ou N; Y é -CH~ 2~-, CH ou O Z-CH~ 2~-, -CH(CH~ 3~)- ou -C(CH~ 3~)~ 2~-; R¹ é hidrogênio, alquila inferior ou acetila; A é C=O ou -(CHR²)~ n~-, em que R² é hidrogênio, alquila inferior ou hidróxi-alquila inferior; B é -(CH~ 2~)~ n~, O, -CH(OH)(CH~ 2~)~ n~-, -CH(CH~ 2~OH)(CH~ 2~)~ n~-, -(CH~ 2~)~ n~ CH(OH)- ou -CH(CH~ 2~OH)-, --- pode ser uma ligação e n é 0 - 4 e a sais de adição ácida farmaceuticamente aceitáveis dos mesmos para a fabricação de medicamentos os quais representam indicações terapêuticas para bloqueadores específicos do subtipo receptor NMDA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98115484 | 1998-08-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9903779A true BR9903779A (pt) | 2000-09-19 |
Family
ID=8232474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9903779-3A BR9903779A (pt) | 1998-08-18 | 1999-08-17 | Derivados de aril-ciclohexilamina |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6184236B1 (pt) |
| JP (1) | JP3455142B2 (pt) |
| KR (1) | KR100341194B1 (pt) |
| CN (1) | CN1141936C (pt) |
| AR (1) | AR021770A1 (pt) |
| AT (1) | ATE326219T1 (pt) |
| AU (1) | AU756408B2 (pt) |
| BR (1) | BR9903779A (pt) |
| CA (1) | CA2280455A1 (pt) |
| DE (1) | DE69931316D1 (pt) |
| HR (1) | HRP990256A2 (pt) |
| HU (1) | HUP9902737A3 (pt) |
| ID (1) | ID23107A (pt) |
| IL (1) | IL131399A0 (pt) |
| MA (1) | MA26677A1 (pt) |
| MY (1) | MY133133A (pt) |
| NO (1) | NO993948L (pt) |
| NZ (1) | NZ337243A (pt) |
| PE (1) | PE20000955A1 (pt) |
| PL (1) | PL334949A1 (pt) |
| SG (1) | SG82014A1 (pt) |
| TR (1) | TR199902015A2 (pt) |
| YU (1) | YU38699A (pt) |
| ZA (1) | ZA995212B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1292581B1 (en) * | 2000-06-06 | 2005-08-10 | Warner-Lambert Company LLC | Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| EP1436258A4 (en) * | 2001-03-08 | 2005-03-23 | Univ Emory | ANTAGONISTS OF THE NMDA RECEPTOR DEPENDENT OF PH |
| DE10153345A1 (de) * | 2001-10-29 | 2003-05-08 | Gruenenthal Gmbh | Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen |
| US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| EP2170334B1 (en) * | 2007-06-29 | 2021-03-17 | Emory University | Nmda receptor antagonists for neuroprotection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4032766A1 (de) | 1990-10-16 | 1992-04-30 | Basf Ag | Phenylpiperidinoylamine und diese enthaltende arzneimittel |
| DE4117904A1 (de) | 1991-05-31 | 1992-12-03 | Basf Ag | Substituierte n-phenylpiperidine |
| EP0503411B1 (de) | 1991-03-14 | 1995-11-29 | BASF Aktiengesellschaft | Substituierte N-Phenylpiperidine und Arzneimittel daraus |
| AU715216B2 (en) * | 1995-10-26 | 2000-01-20 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same |
-
1999
- 1999-08-09 DE DE69931316T patent/DE69931316D1/de not_active Expired - Lifetime
- 1999-08-09 US US09/370,602 patent/US6184236B1/en not_active Expired - Fee Related
- 1999-08-09 AT AT99115114T patent/ATE326219T1/de not_active IP Right Cessation
- 1999-08-13 PE PE1999000826A patent/PE20000955A1/es not_active Application Discontinuation
- 1999-08-13 NZ NZ337243A patent/NZ337243A/xx unknown
- 1999-08-13 IL IL13139999A patent/IL131399A0/xx unknown
- 1999-08-13 CA CA002280455A patent/CA2280455A1/en not_active Abandoned
- 1999-08-13 AR ARP990104079A patent/AR021770A1/es not_active Application Discontinuation
- 1999-08-16 SG SG9903973A patent/SG82014A1/en unknown
- 1999-08-16 MY MYPI99003508A patent/MY133133A/en unknown
- 1999-08-16 JP JP22965899A patent/JP3455142B2/ja not_active Expired - Fee Related
- 1999-08-16 ZA ZA9905212A patent/ZA995212B/xx unknown
- 1999-08-16 HU HU9902737A patent/HUP9902737A3/hu unknown
- 1999-08-16 YU YU38699A patent/YU38699A/sh unknown
- 1999-08-16 ID IDP990791A patent/ID23107A/id unknown
- 1999-08-17 MA MA25736A patent/MA26677A1/fr unknown
- 1999-08-17 PL PL99334949A patent/PL334949A1/xx not_active Application Discontinuation
- 1999-08-17 NO NO993948A patent/NO993948L/no unknown
- 1999-08-17 CN CNB991179110A patent/CN1141936C/zh not_active Expired - Fee Related
- 1999-08-17 KR KR1019990033814A patent/KR100341194B1/ko not_active IP Right Cessation
- 1999-08-17 BR BR9903779-3A patent/BR9903779A/pt not_active IP Right Cessation
- 1999-08-17 AU AU44537/99A patent/AU756408B2/en not_active Ceased
- 1999-08-18 TR TR1999/02015A patent/TR199902015A2/xx unknown
- 1999-08-18 HR HR98115484.2A patent/HRP990256A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR199902015A3 (tr) | 2000-03-21 |
| KR100341194B1 (ko) | 2002-06-20 |
| HU9902737D0 (en) | 1999-10-28 |
| JP2000109429A (ja) | 2000-04-18 |
| MA26677A1 (fr) | 2004-12-20 |
| ID23107A (id) | 2000-02-24 |
| AR021770A1 (es) | 2002-08-07 |
| NZ337243A (en) | 2000-12-22 |
| HUP9902737A2 (hu) | 2000-06-28 |
| NO993948D0 (no) | 1999-08-17 |
| ATE326219T1 (de) | 2006-06-15 |
| NO993948L (no) | 2000-02-21 |
| CA2280455A1 (en) | 2000-02-18 |
| PE20000955A1 (es) | 2000-09-28 |
| AU756408B2 (en) | 2003-01-09 |
| YU38699A (sh) | 2002-03-18 |
| HRP990256A2 (en) | 2000-04-30 |
| CN1141936C (zh) | 2004-03-17 |
| MY133133A (en) | 2007-10-31 |
| CN1248439A (zh) | 2000-03-29 |
| IL131399A0 (en) | 2001-01-28 |
| DE69931316D1 (de) | 2006-06-22 |
| TR199902015A2 (xx) | 2000-03-21 |
| HUP9902737A3 (en) | 2001-01-29 |
| SG82014A1 (en) | 2001-07-24 |
| US6184236B1 (en) | 2001-02-06 |
| ZA995212B (en) | 2000-02-18 |
| PL334949A1 (en) | 2000-02-28 |
| AU4453799A (en) | 2000-05-04 |
| JP3455142B2 (ja) | 2003-10-14 |
| KR20000017343A (ko) | 2000-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0114836A (pt) | Agonistas de receptores beta-3 adrenérgicos e suas aplicações | |
| BRPI0518068A (pt) | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada | |
| BRPI0513672A (pt) | processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)' [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol | |
| BR0210384A (pt) | Heteroarilas multicìclicas substituìdas por quinuclidinas para o tratamento de doença | |
| BR0108894A (pt) | Composição farmacêutica, compostos e processo de preparação de compostos | |
| BRPI0518615A2 (pt) | derivados de malonamida | |
| BR0313846A (pt) | Derivados de dioxano-2-alquilcarbamatos, sua preparação e sua aplicação em terapêutica | |
| HRP20130213T1 (hr) | Spojevi morfinana | |
| BR0114253A (pt) | Antagonistas de receptor de glutamato metabotrópico | |
| HUP0303538A2 (hu) | Tirozin kinázok Tec családjának tiazolil-vegyület inhibitorai és ezeket tartalmazó gyógyszerkészítmények | |
| BRPI0518533A2 (pt) | 18-metil-19-nor-pregn-4-en-21,17- carbolactona, bem como preparados farmacÊuticos contendo as mesmas | |
| BR0008763A (pt) | Derivados de piridopiranoazepinas, a preparação dos mesmos e a respectiva aplicação em terapêutica | |
| BR9908706A (pt) | Derivado de benzofuril-alfa-pirona, composição farmacêutica, acentuador de metabolismo de lipìdeos, inibidor de biossìntese de triglicerìdeos, agente redutor de triglicerìdeos do sangue, agente elevador de hdl do sangue, agente profilático para a arteriosclerose, e, agente de tratamento para a arteriosclerose | |
| BR9903779A (pt) | Derivados de aril-ciclohexilamina | |
| NO903524D0 (no) | Benzopyranforbindelser, fremgangsmaater ved fremstilling og farmasoeytiske blandinger derav. | |
| AR036094A1 (es) | Compuestos derivados de acido sulfonico, composicion farmaceutica y su uso en la preparacion de medicamentos | |
| BRPI0406669A (pt) | Derivados de piridina úteis para inibir sistema de troca de sódio/cálcio | |
| BR0210207A (pt) | Derivados de pirrolidina como inibidores do fator xa | |
| EP0982026A3 (en) | Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers | |
| NO20060277L (no) | Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger | |
| BR0207795A (pt) | Derivados de ácido alcoxicarbonilamino benzóico ou alcoxicarbonilamino tetrazolil fenila como antagonistas de ip | |
| BR0104471A (pt) | Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos | |
| HUP0302276A2 (hu) | Bikalutamidot és tamoxifent tartalmazó gyógyszerkombináció anti-androgén és anti-ösztrogén hatás előidézésére | |
| ATE128116T1 (de) | 2-hydroxy-2-phenylethylaminderivate als beta-3- adrenoceptor agonisten. | |
| YU5899A (sh) | Derivati pirolidina i piperidina, postupak za njihovu proizvodnju, njihova primena za proizvodnju lekova i lekovi koji ih sadrže |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1990 DE 25/02/2009. |